13F 机构持仓

Octagon Capital Advisors LP

NEW YORK NY · SEC CIK 0001839435

2026Q22026Q1 更早 9 个季度 🔒
$11.13亿2026Q2 申报市值
27持仓数
78.5%前十大占比 · 第一大 16.1%
5 / 7新建仓 / 清仓
申报市值走势$11.13亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

DNTH 16.1%
DFTX 12.5%
ABVX 11.9%
COGT 8.2%
ALMS 7.2%
AVBP 6.2%
TSHA 5.9%
BIOA 3.9%
MIRM 3.6%
KYMR 3.2%

2026Q2 买入最多 按季末市值估算

ABVX 加仓+$4,211.02万
DFTX 加仓+$2,399.04万
SMMT 新建仓+$1,821.25万
ANL 新建仓+$1,074.92万
PHVS 加仓+$1,008.77万

2026Q2 卖出最多 按季末市值估算

CENTESSA PHARMAC 清仓-$2,979.00万
KALVISTA PHARMAC 清仓-$2,918.85万
TERNS PHARMACEUT 清仓-$2,794.16万
TRVI 减仓-$2,182.05万
KYMR 减仓-$1,318.70万

2026Q2 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▼占比股数变动股数变动估算买卖额操作
DNTH DIANTHUS THERAPEUTICS INC $1.80亿16.14%1,841,667 -105,000-5.4% -$1,023.54万 减仓
DFTX DEFINIUM THERAPEUTICS INC $1.39亿12.47%2,950,000 510,00020.9% $2,399.04万 加仓
ABVX ABIVAX SA $1.32亿11.89%993,000 316,00046.7% $4,211.02万 加仓
COGT COGENT BIOSCIENCES INC $9,094.50万8.17%2,350,000 00.0% — 不变
ALMS ALUMIS INC $7,965.59万7.16%2,830,700 00.0% — 不变
AVBP ARRIVENT BIOPHARMA INC $6,847.44万6.15%1,971,054 00.0% — 不变
TSHA TAYSHA GENE THERAPIES INC $6,601.10万5.93%9,693,244 833,3339.4% $567.50万 加仓
BIOA BIOAGE LABS INC $4,284.35万3.85%1,748,000 00.0% — 不变
MIRM MIRUM PHARMACEUTICALS INC $3,967.50万3.57%338,900 00.0% — 不变
KYMR KYMERA THERAPEUTICS INC $3,554.77万3.20%310,000 -115,000-27.1% -$1,318.70万 减仓
AKTS AKTIS ONCOLOGY INC $3,096.81万2.78%960,847 00.0% — 不变
XENE XENON PHARMACEUTICALS INC $2,957.64万2.66%490,000 00.0% — 不变
— ERASCA INC 看涨期权 $2,299.16万2.07%1,255,000 1,255,000— $2,299.16万 新建仓
PALI PALISADE BIO INC $2,147.75万1.93%10,276,317 00.0% — 不变
OCUL OCULAR THERAPEUTIX INC $2,037.65万1.83%2,075,000 -1,091,600-34.5% -$1,071.95万 减仓
IRON DISC MEDICINE INC $1,974.78万1.78%270,000 00.0% — 不变
SMMT SUMMIT THERAPEUTICS INC $1,821.25万1.64%1,250,000 1,250,000— $1,821.25万 新建仓
PHVS PHARVARIS N V $1,579.34万1.42%456,721 291,721176.8% $1,008.77万 加仓
ANL ADLAI NORTYE LTD $1,074.92万0.97%934,716 934,716— $1,074.92万 新建仓
DTIL PRECISION BIOSCIENCES INC $1,061.10万0.95%1,350,000 -886,732-39.6% -$696.97万 减仓
DBVT DBV TECHNOLOGIES S A $941.69万0.85%574,200 00.0% — 不变
FTH FAETH THERAPEUTICS INC $902.52万0.81%361,010 361,010— $902.52万 新建仓
— GYRE THERAPEUTICS INC $628.96万0.57%954,416 954,416— $628.96万 新建仓
TRVI TREVI THERAPEUTICS INC $587.48万0.53%315,000 -1,170,000-78.8% -$2,182.05万 减仓
— UNICYCIVE THERAPEUTICS INC $469.00万0.42%1,000,000 00.0% — 不变
— CONTEXT THERAPEUTICS INC $168.94万0.15%3,050,000 -2,200,000-41.9% -$121.86万 减仓
— GOSSAMER BIO INC $127.56万0.11%7,750,000 00.0% — 不变
— CENTESSA PHARMACEUTICALS PLC $00.00%0 -750,000-100.0% -$2,979.00万 清仓
— KALVISTA PHARMACEUTICALS INC $00.00%0 -1,450,000-100.0% -$2,918.85万 清仓
— TERNS PHARMACEUTICALS INC $00.00%0 -530,000-100.0% -$2,794.16万 清仓
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $00.00%0 -719,000-100.0% -$643.50万 清仓
LXEO LEXEO THERAPEUTICS INC $00.00%0 -1,100,000-100.0% -$631.40万 清仓
CATX PERSPECTIVE THERAPEUTICS INC $00.00%0 -791,555-100.0% -$330.08万 清仓
EVMN EVOMMUNE INC $00.00%0 -143,472-100.0% -$329.84万 清仓